Xenogenic cancer vaccines.
In the current review the latest literature data on design of cancer vaccines on the basis of xenogenic tumor-associated antigens and proteins that play an important role in tumor progression have been summarized. The main benefits and disadvantages of xenogenic cancer vaccines, the results of experimental studies and clinical trials, and perspectives of use are analyzed.
Potebnya
G P
GP
R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Vasylkivska str. 45, Kyiv 03022, Ukraine. iris@onconet.kiev.ua
Symchych
T V
TV
Lisovenko
G S
GS
D000818:Animals; D015478:Antigens, Heterophile / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000379:methods
D015478:Antigens, Heterophile; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines